首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors
【24h】

A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors

机译:作为选择性碳酸酐酶VA抑制剂的计算机辅助发现新型潜在的抗肥胖化合物

获取原文
获取原文并翻译 | 示例
           

摘要

The human Carbonic anhydrases (hCA) VA and VB play a key role in ureagenesis, gluconeogenesis, lipogenesis and in the metabolism regulation, thus representing highly popular drug targets. Albeit several hCA inhibitors have been designed and are currently in clinical use, serious drug interactions have been reported due to their poor selectivity. In this perspective, the drug repurposing approach could be a useful tool in order to investigate the drug promiscuity/polypharmacology profile. In this study, virtual screening techniques and in vitro assays were combined to identify novel selective hCA VA inhibitors from among around 94000 compounds. The docking analysis highlighted 12 promising best hits, biologically characterized in terms of their hCA VA inhibitory activity. Interestingly, among them, the anticancer agents fludarabine and lenvatinib and the antiepileptic rufinamide were able to selectively inhibit the enzyme activity in the micromolar range, while a pyrido-indole derivative, the homovanillic acid sulfate and the desacetyl metabolite of the antibacterial cephapirin in the nanomolar range. (C) 2019 Elsevier Masson SAS. All rights reserved.
机译:人类碳酸酐酶(HCA)VA和VB中的尿素生成,糖异生,脂肪生成和在代谢调控中发挥关键作用,从而代表了广受欢迎的药物靶标。虽然几个HCA抑制剂的设计和目前在临床上使用,严重的药物相互作用进行了报道,由于其选择性差。从这个角度来看,药品再利用的做法可能是为了研究药物滥交/ polypharmacology轮廓的有用工具。在这项研究中,虚拟筛选技术和体外测定法组合以从大约94000的化合物中鉴定新的选择性HCA VA抑制剂。对接分析突出12个有为最佳匹配结果,生物特征的HCA VA抑制活性方面出发。有趣的是,其中,所述抗癌剂氟达拉滨和lenvatinib和抗癫痫卢非酰胺能够选择性地抑制在微摩尔范围内的酶活性,而吡啶并吲哚衍生物中,高香草酸硫酸盐和抗菌头孢匹林的在纳摩尔的去乙酰基代谢物范围。 (c)2019年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号